During the past decade, Unidad Medica para la Salud Integral conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 3 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 3 clinical trials were completed. i.e. 30% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Unidad Medica para la Salud Integral" #1 collaborator was "Brigham and Women's Hospital" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Unidad Medica para la Salud Integral" are "Type 2 Diabetes Mellitus" (3 trials), "Idiopathic Pulmonary Fibrosis" (2 trials), "Obesity" (2 trials), "Type 2 Diabetes" (2 trials) and "Type2 Diabetes" (2 trials). Many other conditions were trialed in "Unidad Medica para la Salud Integral" in a lesser frequency.

Most popular intervention types in "Unidad Medica para la Salud Integral" are "Drug" (12 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Tirzepatide" (6 trials), "PRM-151 (Zinpentraxin Alfa)" (2 trials), "Dulaglutide" (1 trials) and "Insulin Efsitora Alfa" (1 trials). Other intervention names were less common.

The vast majority of trials in "Unidad Medica para la Salud Integral" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Unidad Medica para la Salud Integral". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Unidad Medica para la Salud Integral, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Unidad Medica para la Salud Integral, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".